Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant
Yingxia Wen, Hung V. Trinh, Christine Linton, et al.
PLoS ONE (2018) Vol. 13, Iss. 4, pp. e0194266-e0194266
Open Access | Times Cited: 18

Showing 18 citing articles:

3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope–specific plasma cells and humoral immunity in nonhuman primates
Sudhir Pai Kasturi, Mohammed Ata Ur Rasheed, Colin Havenar‐Daughton, et al.
Science Immunology (2020) Vol. 5, Iss. 48
Open Access | Times Cited: 122
Recombinant therapeutic proteins degradation and overcoming strategies in CHO cells
Shao‐Lei Geng, Xiaojie Zhao, Xi Zhang, et al.
Applied Microbiology and Biotechnology (2024) Vol. 108, Iss. 1
Open Access | Times Cited: 11
SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies
Shikha Shrivastava, Joshua M. Carmen, Zhongyan Lu, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 12
Impact of T h 1 CD4 Follicular Helper T Cell Skewing on Antibody Responses to an HIV-1 Vaccine in Rhesus Macaques
Anil Verma, Brian Schmidt, Sonny R. Elizaldi, et al.
Journal of Virology (2019) Vol. 94, Iss. 6
Open Access | Times Cited: 35
Clinical trials and recent progress in HIV vaccine development
Akmal Zubair, Bushra Bibi, Faiza Habib, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 5
Closed Access | Times Cited: 3
Identification and CRISPR/Cas9 Inactivation of the C1s Protease Responsible for Proteolysis of Recombinant Proteins Produced in CHO Cells
Sophia W. Li, Bin Yu, Gabriel Byrne, et al.
Biotechnology and Bioengineering (2019) Vol. 116, Iss. 9, pp. 2130-2145
Open Access | Times Cited: 29
Malaria transmission-blocking conjugate vaccine in ALFQ adjuvant induces durable functional immune responses in rhesus macaques
Puthupparampil V. Scaria, Charles Anderson, Olga Muratova, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 19
ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type
Luca Schifanella, Susan W. Barnett, Massimiliano Bissa, et al.
PLoS Pathogens (2019) Vol. 15, Iss. 12, pp. e1008121-e1008121
Open Access | Times Cited: 22
Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production
Sara M. O’Rourke, Gabriel Byrne, Gwen P. Tatsuno, et al.
PLoS ONE (2018) Vol. 13, Iss. 8, pp. e0197656-e0197656
Open Access | Times Cited: 19
Correction: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type
Luca Schifanella, Susan W. Barnett, Massimiliano Bissa, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 4, pp. e1008531-e1008531
Open Access | Times Cited: 15
TitrationAnalysis: a tool for high throughput binding kinetics data analysis for multiple label-free platforms
Kan Li, Richard H.C. Huntwork, Gillian Q. Horn, et al.
Gates Open Research (2023) Vol. 7, pp. 107-107
Open Access | Times Cited: 5
Gene editing in CHO cells to prevent proteolysis and enhance glycosylation: Production of HIV envelope proteins as vaccine immunogens
Sophia W. Li, Meredith Wright, John F. Healey, et al.
PLoS ONE (2020) Vol. 15, Iss. 5, pp. e0233866-e0233866
Open Access | Times Cited: 14
Glycan Profiles of gp120 Protein Vaccines from Four Major HIV-1 Subtypes Produced from Different Host Cell Lines under Non-GMP or GMP Conditions
Shixia Wang, Yegor Voronin, Peng Zhao, et al.
Journal of Virology (2020) Vol. 94, Iss. 7
Open Access | Times Cited: 13
Humoral Response to the HIV-1 Envelope V2 Region in a Thai Early Acute Infection Cohort
Hung V. Trinh, Neelakshi Gohain, Peter Pham, et al.
Cells (2019) Vol. 8, Iss. 4, pp. 365-365
Open Access | Times Cited: 10
Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIVmac251 acquisition in macaques
Mohammad Arif Rahman, Manuel Becerra‐Flores, Y. Patskovsky, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
TitrationAnalysis: a tool for high throughput binding kinetics data analysis for multiple label-free platforms
Kan Li, Richard H.C. Huntwork, Gillian Q. Horn, et al.
Gates Open Research (2024) Vol. 7, pp. 107-107
Open Access
Loss of HIV candidate vaccine efficacy in male macaques by mucosal nanoparticle immunization rescued by V2-specific response
Mohammad Arif Rahman, Massimiliano Bissa, Hanna B. Scinto, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine for production
Sara M. O’Rourke, Gabriel Byrne, Gwen P. Tatsuno, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2018)
Open Access | Times Cited: 1
Page 1

Scroll to top